Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 107.27M | 109.58M | 83.96M | 74.52M | 61.54M | 61.15M |
Gross Profit | 34.35M | 33.87M | 23.40M | 20.40M | 17.32M | 12.88M |
EBITDA | 17.58M | 18.02M | 7.53M | 8.04M | 3.56M | -1.12M |
Net Income | 12.14M | 11.50M | 4.12M | 4.93M | 1.18M | -2.49M |
Balance Sheet | ||||||
Total Assets | 132.13M | 128.72M | 79.31M | 80.59M | 74.39M | 66.41M |
Cash, Cash Equivalents and Short-Term Investments | 27.85M | 35.51M | 15.25M | 19.25M | 23.55M | 16.13M |
Total Debt | 597.00K | 804.00K | 1.21M | 1.51M | 545.00K | 1.23M |
Total Liabilities | 81.07M | 77.92M | 38.24M | 42.02M | 43.36M | 36.28M |
Stockholders Equity | 51.07M | 50.80M | 41.08M | 38.58M | 31.04M | 30.13M |
Cash Flow | ||||||
Free Cash Flow | -10.31M | 31.70M | -2.37M | -2.86M | 9.00M | -4.05M |
Operating Cash Flow | -4.61M | 36.60M | -397.00K | -99.00K | 9.79M | -3.33M |
Investing Cash Flow | -2.25M | -8.98M | -1.73M | -2.53M | -773.00K | -1.77M |
Financing Cash Flow | -7.74M | -4.38M | -1.94M | -1.72M | -1.54M | -1.63M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | £143.47M | 9.02 | 16.03% | 4.21% | -6.20% | 83.31% | |
78 Outperform | £587.53M | 115.88 | 4.18% | 1.31% | 14.69% | ― | |
77 Outperform | £200.56M | 13.78 | 25.95% | 0.85% | 8.40% | 69.42% | |
65 Neutral | $10.77B | 15.80 | 5.51% | 1.90% | 3.03% | -26.66% | |
61 Neutral | £40.87M | ― | -48.45% | 3.36% | -4.29% | -97.73% | |
53 Neutral | £265.65M | 205.36 | -5.28% | 0.80% | -8.12% | -794.85% | |
52 Neutral | £24.10M | ― | -7.06% | 0.65% | -22.37% | -192.17% |
MS International PLC has announced that an employee has exercised options for 13,334 ordinary shares at an exercise price of £1.41. This transaction was fulfilled from shares already held in treasury. As a result of this exercise, the total voting rights now stand at 16,173,750, which is relevant for shareholders to calculate their interest in the company under regulatory guidelines.